2023
|
Invention
|
Process of making stable abuse-deterrent oral formulations.
The present disclosure relates to cu... |
2020
|
Invention
|
Abuse-deterrent drug formulations.
An abuse-deterrent pharmaceutical composition has been develo... |
|
Invention
|
Abuse-deterrent pharmaceutical compositions of opioids and other drugs.
An abuse-deterrent pharm... |
|
G/S
|
Providing information on pain management; providing a website featuring information on pain manag... |
2019
|
G/S
|
Providing a website featuring resources, namely, non-downloadable publications in the nature of b... |
|
Invention
|
Tamper-resistant pharmaceutical compositions of opioids and other drugs. Tamper-resistant pharmac... |
2018
|
Invention
|
Process of making stable abuse-deterrent oral formulations. The present disclosure relates to cur... |
|
Invention
|
Tamper-resistant pharmaceutical compositions of opioids and other drugs.
Tamper-resistant pharma... |
2017
|
Invention
|
Abuse-deterrent pharmaceutical compositions of opioids and other drugs. An abuse-deterrent pharma... |
|
Invention
|
Abuse-deterrent drug formulations. An abuse-deterrent pharmaceutical composition has been develop... |
2016
|
Invention
|
Process of making more stable abuse-deterrent oral formulations. The present disclosure relates t... |
|
G/S
|
Providing health information regarding prescription pharmaceutical preparations |
2015
|
G/S
|
Pharmaceutical preparations, namely, analgesics and opioids,
and abuse-deterrent, extended relea... |
|
G/S
|
Pharmaceutical preparations, namely, analgesics and opioids, and abuse-deterrent, extended releas... |
2014
|
Invention
|
Tamper-resistant pharmaceutical compositions of opioids and other drugs. Tamper-resistance pharma... |
|
Invention
|
Pharmaceutical compositions for sleep apnea.
Pharmaceutical compositions are provided for the ph... |
2012
|
Invention
|
Abuse-deterrent pharmaceutical compositions of opiods and other drugs. An abuse-deterrent pharmac... |
2010
|
Invention
|
Modified release compositions of milnacipran. max of 4-10 hours. |
2008
|
G/S
|
pharmaceutical preparations for the treatment of Central Nervous System disorders including pain ... |
|
Invention
|
Sustained release compositions of drugs.
A sustained release pharmaceutical composition has been... |
2007
|
G/S
|
Pharmaceutical preparations, namely, [ psychotropics, antidepressants, ] analgesics, opiates, [ s... |
|
Invention
|
Antihistamine combination. A once daily formulation containing the combination of a non-sedating ... |
|
Invention
|
Antihistamine combination.
A once daily formulation containing the combination of a non-sedating... |
|
Invention
|
Combination therapy for otitis with antiseptic and ph adjustment.
Otitis is treated with a combi... |
|
Invention
|
Combination therapy for otitis with antiseptic and ph adjustment. Otitis is treated with a combin... |
|
Invention
|
Stabilized transdermal bupropion preparations. Pharmaceutical compositions for transdermal admini... |
2006
|
Invention
|
Methylene blue derivatives.
Pharmaceutical compositions comprising a fatty acid salt, a dicarbox... |
|
Invention
|
Salts of methylene blue and its derivatives. Pharmaceutical compositions comprising a fatty acid ... |
|
Invention
|
Topical pharmaceutical foam composition. A stable topical alcohol-free aerosol foam containing on... |
|
Invention
|
Gelled periodontal anesthetic preparation.
A composition for anesthetizing oral or buccal tissue... |
|
Invention
|
Topical delivery with a carrier fluid. Aerosol spray formulations capable of delivering high conc... |
|
Invention
|
Compositions for topical enzymatic debridement. Formulations are described for the treatment by e... |
|
Invention
|
Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active ag... |
2005
|
Invention
|
Pharmaceutical compositions for sleep disorders. Pharmaceutical compositions are provided for the... |